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Abstract
Circumscribed choroidal hemangioma (CCH), a relatively rare benign tumor, can cause differential diagnostic 
problems by its atypical appearance at the time of presentation. Ancillary test such as fluorescein angiography, 
indocyanin green angiography, ultrasonography, computer tomography (CT), magnetic resonance imaging (MR!) 
bring not always additional information and their results are not always pathognomic.
We retrospectively reviewed the clinical records of 40 patients with the ultrasonographical diagnosis of CCH 
compiled in the last 20 years. Ultrasonography appeared to be uniform in its lesion characteristics and reliable in 
the diagnosis. During a mean follow-up time of 7.4 years there were no clinical or posttherapeutical developments 
that made a correction of the diagnosis necessary.
Introduction
Circumscribed choroidal hemangioma (CCH) is a rare 
benign primary intraocular tumor with an unclear 
pathogenesis, probably already present at birth [1-3].
The tumor can be detected and well diagnosed with an 
accurate indirect ophthalmoscopic or biomicroscopic 
examination if present in its characteristic appearance 
of an orange-red or salmon colored smoothly elevated 
lesion with indistinct borders.
It is nearly always located in the temporal quadrants 
posterior to the equator two disc diameters or less from 
the fovea or optic disc [4-7]. The prolonged presence of 
the tumor frequently gives rise to secondary changes in 
the overlying retinal pigment epithelium (atrophy, pro­
liferation, fibrous and osseous metaplasia) and in or on 
the neuroretina (cystic degeneration, neovasculariza­
tion, serous detachment) [2, 6, 8, 9]. These changes, 
eventually combined with some enlargement of the 
lesion cause on the one hand the symptoms (blurred 
vision, metamorphopsia) and on the other hand diag­
nostic confusion by the atypical aspect and by the late 
time of presentation [10, 11]. In the past this could 
result in an enucleation of the eye because of a clini­
cally expected choroidal melanoma [1, 2,5, 12]. At the 
present time because of the increased awareness of the 
clinical features of CCH by the trained ophthalmolo­
gist and in some questionable cases the improvements 
in the diagnostic possibilities (fluorescein angiogra­
phy, indocyanin green angiography, ultrasonography, 
computer tomography (C,T.) and magnetic resonance 
imaging (MRI)), the frequency of an erroneous diag­
nosis has been greatly reduced [4, 7].
Despite these modern techniques, the limited expe­
rience of the individual ophthalmologist with regard 
to this tumor still gives rise to hesitation and conse­
quently extensive or even overdone diagnostic work­
up. This study reports on these diagnostic problems and 
their resolution by an already well-known non-invasive 
technique with good results: ultrasonography.
186
Table 1, Ultrasonographic characteristics of CCH
Topographic * dome shaped, close to disc, macula
* low profile (prominence mostly < 6 mm)
* base/prominence ratio < 3
* no choroidal excavation
* sec, ret. detachment: frequent
Quantitative * high reflective (80-100%)
* regular
* if osseous metaplasia: attenuation/shadow
Kinetic * no vascularity
Methods
We reviewed retrospectively over a period of 20 years 
(1974-94) the clinical records of the patients with the 
ultrasonographical diagnosis of CCH and searched for 
the histopathological diagnosis of CCH in all the enu­
cleated eyes with a clinically suspected malignancy in 
the same period of time.
The ultrasonographic examination was per­
formed with standardised A-mode (Kretztechnik 
7200MA) and contact B-mode equipment (Bronson- 
Turner/Grumman, Ophthascan S/Biophysique Med­
ical) with an unfocused 8 MHz and a focused 
10 MHtransducer respectively. When the lesion was 
detected, the prominence, the internal reflectivity, the 
spike-regularity, the attenuation and the eventual signs 
of vascularity were examined with the A-mode instru­
ment and method as described by Ossoinig [13]. With 
the B-mode technique the base, the shape, signs for cal­
cification and choroidal excavation of the mass lesion 
were studied. The results were photographed (Polaroid 
film 667) for accurate documentation and measure­
ments. When the tumor showed the ultrasonographic 
characteristics of Table 1, the diagnosis of CCH was 
made until recall.
Figure L  (Top) Standardised A-mode echogram of a 3.2 mm promi­
nent (white arrows) CCH at tissue sensitivity. Note the high internal 
reflectivity (open arrow). {Bottom) At a 20 dB lower sensitivity set­
ting (10 times lower amplification) the CCH infrastructure still gives 
rise to intratumoral echospikes (between white arrows).
the left eye. At the moment of the tumor detection their 
age ranged from 15 to 79 years (mean 49.2 yrs).
Most of the patients (83%) presented with the 
symptoms and signs of the tumor in the 4th to 6th 
decade, 50% in the 5th decade.
Patients
During the observation period not a single eye was 
diagnosed as CHH by histopathological exam. 324 
Eyes were enucleated, 318 of them harbouring a uveal 
melanoma. In 5 cases a single metastatic lesion and 
in one case extensive SHMD were the reason for an 
erroneous removal of the eye.
The ultrasonographic signs of CCH were seen in 
40 patients, 17 female, 23 male, with 18 times a tumor 
location in the right and 22 times a tumor location in
Results
Of the 40 patients referred to our department 21 were 
send by a general ophthalmologist and 19 came from 
different university clinics. The provisional diagnosis 
was ‘tumor’ in 23, CCH in 12, retinal detachment in 
3, central serous retinopathy in 1 and cataract in 1 case 
after general ophthalmological examination.
In only 2 of our patients, the tumor was nasally 
adjacent to the disc. In all the other patients the lesions
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Figure 2. B-mode echogram of a dome shaped iuxtapapillary CCH, 
with secondary retinal detachment. The reflectivity of the mass lesion 
is close to that of orbital fat. V.C.: vitreous cavity, O.N.: optic nerve.
were located in the temporal quadrants close to the 
fovea and the disc or partially subfoveal. The main rea­
son for diagnostic confusion was in 9 patients the color 
of the lesion (pale, white-grayish), in 8 patients sec­
ondary pigment alterations and in 4 patients an exten­
sive retinal detachment. In 1 patient the media were 
opaque. With the additional information of the fluo­
rescein angiography there was still uncertainty about 
the diagnosis in 14 cases. In 2 patients a computer 
tomogram (CT) and in 4 patients a magnetic resonance 
image (MRI) was made but not helpful for the diag­
nosis. Ultrasonography showed in all cases the same 
ultrasonographic pattern as described in Table 1 and 
shown in Figs 1 and 2. The tumor-prominence varied 
from L5 to 6 mm (mean 2.8 mm), the tumor basis 
from 3 to 13.5 mm (mean 7.2 mm). The ratio tumor 
basis/tumor prominence was < 3 in all cases.
Enlargement of the lesion was observed in 2 cas­
es, detection of superficial calcium deposits (osseous
metaplasia RPE) in another 2 patients. The maximum 
prominence measured in our series was 6 mm.
During the mean follow-up period of 7.4 years (2 
months-20 years) there was no clinical or postther- 
apeutical development that made a correction in the 
diagnosis necessary. No patient of this relative young 
population was lost for follow-up*
Discussion
The clinical diagnosis of CCH is not always so straight­
forward as sometimes suggested in the literature [4, 
10]. The very limited experience of the individual oph­
thalmologist and the chronic secondary changes creat­
ed by the benign tumor in the surrounding tissue are 
responsible for the diagnostic problems.
Ancillary diagnostic tests are, either not uniform 
in their results (visual fields, fluorescein angiography), 
a burden to the patient (P32), or only employed in a 
limited number of patients [ICG* CT, MRI]. Although 
fluorescein angiography is helpful in identifying CCH 
(a coarse vascular pattern of fluorescence in the (pre- 
arterial phase and a diffuse multiluculated pattern in the 
outer polycystic degenerated retina in the later stages) 
changes in the overlying RPE may interfere in such 
a way with its characteristic angiographic pattern that 
they are not always pathognomic for the lesion [14- 
16]. Indocyanine green, unlike fluorescein does hardly 
leak from the choroidal vessels, giving rise to a some­
times even very characteristic angiographic pattern in 
CCH [12, 26]. Despite better results the experience 
with ICG is very limited. The same holds true for CT 
and MRI. In the differentiation of intraocular tumors 
in adults the results CT are poor despite high resolu­
tion thin slice techniques, enlargement of images and 
contrast enhancement. The small differences in density 
do not allow tissue-typing [17]. The non-ionizing MRI 
technique including gadolinium contrast enhancement 
is useful in tumor detection and tumor extension but of 
very limited value in tumor differentiation, especially 
when the paramagnetic effect of melanin is absent. The 
data acquisition time of this expensive examination is 
relatively long while the evaluation of more cases is 
necessary to determine if the preliminary observations 
untili now are consistent. With CT and MRI only mass­
es with a prominence > 3 mm are clearly visible. The 
radioactive phosphorus uptake test (P32), gives signif­
icantly lower uptake counts in CCH than in compara­
bly sized melanomas, but it is an invasive test, which 
requires a peritomy and special equipment. It is used
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Figure 3. A, B-mode echogram of a 4.3 (white arrows) mm dome 
shaped choroidal melanoma. (A) close to the optic nerve (0,N,), 
(B) note the choroidal excavation (black arrows). (C) note the low 
reflectivity (open arrow). V.C.: vitreous cavity.
less frequently today because of the better recognition 
of intraocular lesions with non-invasive techniques and 
of the more definite diagnostic techniques such as fine 
needle biopsy in the questionable cases.
Ultrasonography enables the detection of mass- 
lesions with a prominence of > 0.3 mm. When the 
prominence is > 1.5 mm CCH can be differentiated 
from other tumors because the ultrasonographic char­
acteristics are uniform and quite different from other 
intraocular mass-lesions such as choroidal melanoma 
(Fig, 3) [shape: dome or mushroom, reflectivity: low 
to medium, vascularity and choroidal excavation fre­
quently positive]. In choroidal metastasis the B-mode 
echogram shows mostly a broad based choroidal infil­
tration of variable prominence and reflectivity level. 
Only a choroidal naevus can give the same echogram 
as observed in a slightly elevated CCH. There is a lot
of experience with this inexpensive examination tech­
nique that can always be near the ophthalmologist’s 
hands.
In the 40 patients we followed for a long time it 
appeared reliable.
In conclusion for our series. Only two examinations 
-  ophthalmoscopy and ultrasonography -  could ascer­
tain the most probable diagnosis of CCH in all the 
cases.
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